May 26, 2015
Chugai Pharmaceutical said on May 25 that it has filed a new drug application (NDA) in Japan for the topical combination drug M8010 (maxacalcitol + betamethasone butyrate propionate) for the treatment of psoriasis vulgaris. The once-daily preparation has been developed...read more